Share Price and Basic Stock Data
Last Updated: December 12, 2025, 7:37 pm
| PEG Ratio | 4.82 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cenlub Industries Ltd operates within the engineering sector, focusing on manufacturing lubrication systems. The company has demonstrated a commendable growth trajectory, with revenues rising from ₹52.42 Cr in FY 2022 to ₹53.93 Cr in FY 2023. This upward trend continues, as the company’s sales for FY 2024 are reported at ₹71.52 Cr, indicating a robust growth model. The quarterly sales figures also highlight this momentum; for instance, in September 2023, sales surged to ₹19.36 Cr and further climbed to ₹20.14 Cr by December 2023. However, the subsequent quarters show fluctuations, as sales dipped to ₹16.88 Cr by September 2024. This volatility raises questions about seasonal demand or operational challenges, which investors should closely monitor. Overall, Cenlub appears to have a solid foundation, yet the revenue fluctuations suggest that maintaining this growth trajectory may require strategic interventions.
Profitability and Efficiency Metrics
The profitability metrics of Cenlub Industries reveal a mixed bag. The operating profit margin (OPM) stood at 16.92% for March 2025, reflecting a competitive edge in managing costs relative to sales. However, this figure is down from the peak of 29.71% recorded in December 2022, indicating that rising expenses may be squeezing margins. The company’s net profit for FY 2025 is reported at ₹8.94 Cr, translating to an earnings per share (EPS) of ₹19.17, which is commendable within the engineering sector. Return on equity (ROE) at 14.7% and return on capital employed (ROCE) at 20.5% also suggest that the company is efficiently using its resources to generate profits. However, the cash conversion cycle has lengthened to 105 days, which could signal potential liquidity issues. Investors should weigh these profitability indicators against the backdrop of rising operational costs and changing market conditions.
Balance Sheet Strength and Financial Ratios
Cenlub’s balance sheet exhibits a blend of strengths and vulnerabilities. The company has reported total reserves of ₹63.46 Cr against borrowings of ₹4.27 Cr, showcasing a strong capital base and low leverage. This translates into a debt-to-equity ratio that appears conservative, providing a cushion against economic downturns. The interest coverage ratio (ICR) at 2.97x indicates that the company can comfortably meet its interest obligations, suggesting a stable financial footing. However, the price-to-book value (P/BV) ratio of 1.36x is slightly elevated compared to industry norms, which may imply that the stock is priced at a premium. Moreover, with a working capital days figure of 11.49, the company is maintaining a healthier operational efficiency. While the balance sheet reflects a solid foundation, it is crucial to monitor how the company manages its capital and liquidity moving forward.
Shareholding Pattern and Investor Confidence
The shareholding structure of Cenlub Industries reveals a stable promoter presence, with promoters holding 51.34% of the company as of June 2023. This level of ownership can bolster investor confidence, as it indicates a commitment from the founding members to the company’s long-term vision. The public shareholding stands at 48.66%, with the number of shareholders increasing from 4,739 in December 2022 to 8,687 in September 2025, reflecting growing interest among retail investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may raise questions about broader market confidence in the stock. The increasing public shareholding could indicate a positive trend, but the lack of institutional backing might limit liquidity and price stability. Investors should consider these dynamics when evaluating their position in Cenlub Industries.
Outlook, Risks, and Final Insight
Looking ahead, Cenlub Industries faces a mix of opportunities and risks. The company’s focus on engineering and lubrication systems positions it well in a growing sector, but the volatility in quarterly revenues and fluctuating profit margins could pose challenges. Additionally, the lengthening cash conversion cycle raises concerns about working capital management, which could impact operational efficiency. Investors might also want to keep an eye on macroeconomic factors, such as inflation and material costs, which could further squeeze profit margins. While the solid balance sheet and increasing public interest are encouraging, the absence of institutional investors may limit the stock’s growth potential. Ultimately, investors should weigh the company’s operational strengths against its financial risks and market dynamics to make informed decisions on their holdings in Cenlub Industries.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 209 Cr. | 613 | 1,086/541 | 16.6 | 218 | 0.49 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 23.6 Cr. | 78.5 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.40 Cr. | 14.8 | 17.7/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.01 Cr. | 13.0 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 56.9 Cr. | 0.61 | 7.14/0.48 | 6.84 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,591.34 Cr | 456.12 | 51.17 | 119.01 | 0.29% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.74 | 12.83 | 14.35 | 15.62 | 11.13 | 12.21 | 19.36 | 20.14 | 19.81 | 19.09 | 16.88 | 16.71 | 20.68 |
| Expenses | 13.15 | 10.98 | 12.00 | 10.98 | 11.13 | 10.04 | 15.54 | 16.79 | 16.95 | 15.97 | 14.16 | 14.42 | 17.18 |
| Operating Profit | 3.59 | 1.85 | 2.35 | 4.64 | 0.00 | 2.17 | 3.82 | 3.35 | 2.86 | 3.12 | 2.72 | 2.29 | 3.50 |
| OPM % | 21.45% | 14.42% | 16.38% | 29.71% | 0.00% | 17.77% | 19.73% | 16.63% | 14.44% | 16.34% | 16.11% | 13.70% | 16.92% |
| Other Income | 0.55 | 0.34 | 0.13 | 0.29 | 0.50 | 0.12 | 0.27 | 0.36 | 0.50 | 0.38 | 0.55 | 0.65 | 0.96 |
| Interest | 0.13 | 0.11 | 0.09 | 0.03 | 0.03 | 0.11 | 0.13 | 0.07 | 0.10 | 0.05 | 0.09 | 0.16 | 0.11 |
| Depreciation | 0.23 | 0.19 | 0.37 | 0.13 | 0.11 | 0.20 | 0.18 | 0.23 | 0.22 | 0.17 | 0.19 | 0.20 | 0.28 |
| Profit before tax | 3.78 | 1.89 | 2.02 | 4.77 | 0.36 | 1.98 | 3.78 | 3.41 | 3.04 | 3.28 | 2.99 | 2.58 | 4.07 |
| Tax % | 11.38% | 25.40% | 25.25% | 25.58% | 41.67% | 25.25% | 22.22% | 28.45% | 30.26% | 25.30% | 36.12% | 25.19% | 35.38% |
| Net Profit | 3.35 | 1.41 | 1.51 | 3.54 | 0.21 | 1.48 | 2.94 | 2.44 | 2.11 | 2.46 | 1.91 | 1.94 | 2.64 |
| EPS in Rs | 7.18 | 3.02 | 3.24 | 7.59 | 0.45 | 3.17 | 6.31 | 5.23 | 4.53 | 5.28 | 4.10 | 4.16 | 5.66 |
Last Updated: May 31, 2025, 6:34 am
Below is a detailed analysis of the quarterly data for Cenlub Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 20.68 Cr.. The value appears strong and on an upward trend. It has increased from 16.71 Cr. (Dec 2024) to 20.68 Cr., marking an increase of 3.97 Cr..
- For Expenses, as of Mar 2025, the value is 17.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.42 Cr. (Dec 2024) to 17.18 Cr., marking an increase of 2.76 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.50 Cr.. The value appears strong and on an upward trend. It has increased from 2.29 Cr. (Dec 2024) to 3.50 Cr., marking an increase of 1.21 Cr..
- For OPM %, as of Mar 2025, the value is 16.92%. The value appears strong and on an upward trend. It has increased from 13.70% (Dec 2024) to 16.92%, marking an increase of 3.22%.
- For Other Income, as of Mar 2025, the value is 0.96 Cr.. The value appears strong and on an upward trend. It has increased from 0.65 Cr. (Dec 2024) to 0.96 Cr., marking an increase of 0.31 Cr..
- For Interest, as of Mar 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.16 Cr. (Dec 2024) to 0.11 Cr., marking a decrease of 0.05 Cr..
- For Depreciation, as of Mar 2025, the value is 0.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.20 Cr. (Dec 2024) to 0.28 Cr., marking an increase of 0.08 Cr..
- For Profit before tax, as of Mar 2025, the value is 4.07 Cr.. The value appears strong and on an upward trend. It has increased from 2.58 Cr. (Dec 2024) to 4.07 Cr., marking an increase of 1.49 Cr..
- For Tax %, as of Mar 2025, the value is 35.38%. The value appears to be increasing, which may not be favorable. It has increased from 25.19% (Dec 2024) to 35.38%, marking an increase of 10.19%.
- For Net Profit, as of Mar 2025, the value is 2.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.94 Cr. (Dec 2024) to 2.64 Cr., marking an increase of 0.70 Cr..
- For EPS in Rs, as of Mar 2025, the value is 5.66. The value appears strong and on an upward trend. It has increased from 4.16 (Dec 2024) to 5.66, marking an increase of 1.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.48 | 29.82 | 31.34 | 35.67 | 37.11 | 48.10 | 39.04 | 40.96 | 52.42 | 53.93 | 71.52 | 73.37 | 68.25 |
| Expenses | 23.31 | 26.16 | 28.08 | 30.67 | 31.38 | 40.13 | 35.11 | 34.54 | 43.64 | 45.11 | 59.32 | 61.74 | 58.01 |
| Operating Profit | 2.17 | 3.66 | 3.26 | 5.00 | 5.73 | 7.97 | 3.93 | 6.42 | 8.78 | 8.82 | 12.20 | 11.63 | 10.24 |
| OPM % | 8.52% | 12.27% | 10.40% | 14.02% | 15.44% | 16.57% | 10.07% | 15.67% | 16.75% | 16.35% | 17.06% | 15.85% | 15.00% |
| Other Income | 0.57 | 0.52 | 0.72 | 0.93 | 1.01 | 1.45 | 2.20 | 1.37 | 1.40 | 1.27 | 1.25 | 2.54 | 2.76 |
| Interest | 1.98 | 2.01 | 1.90 | 1.81 | 1.21 | 1.22 | 1.10 | 1.07 | 0.59 | 0.26 | 0.41 | 0.40 | 0.46 |
| Depreciation | 0.36 | 0.40 | 0.55 | 0.75 | 0.78 | 1.01 | 0.97 | 0.96 | 0.92 | 0.80 | 0.83 | 0.83 | 0.87 |
| Profit before tax | 0.40 | 1.77 | 1.53 | 3.37 | 4.75 | 7.19 | 4.06 | 5.76 | 8.67 | 9.03 | 12.21 | 12.94 | 11.67 |
| Tax % | 32.50% | 32.20% | 34.64% | 35.01% | 26.95% | 31.29% | 32.27% | 30.38% | 19.26% | 26.14% | 26.45% | 30.91% | |
| Net Profit | 0.28 | 1.19 | 1.00 | 2.19 | 3.48 | 4.94 | 2.76 | 4.01 | 7.00 | 6.67 | 8.97 | 8.94 | 8.01 |
| EPS in Rs | 0.68 | 2.89 | 2.43 | 5.32 | 7.46 | 10.59 | 5.92 | 8.60 | 15.01 | 14.30 | 19.24 | 19.17 | 17.18 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 325.00% | -15.97% | 119.00% | 58.90% | 41.95% | -44.13% | 45.29% | 74.56% | -4.71% | 34.48% | -0.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -340.97% | 134.97% | -60.10% | -16.95% | -86.08% | 89.42% | 29.27% | -79.28% | 39.20% | -34.82% |
Cenlub Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 34% |
| 3 Years: | 8% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 54% |
| 3 Years: | 30% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 10, 2025, 4:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.12 | 4.12 | 4.12 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| Reserves | 9.74 | 10.93 | 11.99 | 15.16 | 18.65 | 23.55 | 24.77 | 28.89 | 35.88 | 42.57 | 51.25 | 59.98 | 63.46 |
| Borrowings | 14.27 | 15.37 | 11.37 | 16.91 | 10.68 | 10.19 | 12.46 | 8.03 | 6.02 | 4.88 | 4.24 | 4.56 | 4.27 |
| Other Liabilities | 7.56 | 7.83 | 9.49 | 9.63 | 11.55 | 13.92 | 12.10 | 14.33 | 12.99 | 10.61 | 17.49 | 21.08 | 19.62 |
| Total Liabilities | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
| Fixed Assets | 5.69 | 6.88 | 9.86 | 20.50 | 18.98 | 20.87 | 20.65 | 20.08 | 19.39 | 19.77 | 17.43 | 23.46 | 25.53 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.27 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Investments | 1.04 | 4.56 | 1.60 | 0.07 | 0.06 | 0.05 | 0.02 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 28.96 | 26.81 | 25.51 | 25.52 | 26.18 | 31.40 | 33.32 | 35.77 | 40.16 | 42.95 | 60.21 | 66.80 | 66.48 |
| Total Assets | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
Below is a detailed analysis of the balance sheet data for Cenlub Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.66 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.66 Cr..
- For Reserves, as of Sep 2025, the value is 63.46 Cr.. The value appears strong and on an upward trend. It has increased from 59.98 Cr. (Mar 2025) to 63.46 Cr., marking an increase of 3.48 Cr..
- For Borrowings, as of Sep 2025, the value is 4.27 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4.56 Cr. (Mar 2025) to 4.27 Cr., marking a decrease of 0.29 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.62 Cr.. The value appears to be improving (decreasing). It has decreased from 21.08 Cr. (Mar 2025) to 19.62 Cr., marking a decrease of 1.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 92.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
- For Fixed Assets, as of Sep 2025, the value is 25.53 Cr.. The value appears strong and on an upward trend. It has increased from 23.46 Cr. (Mar 2025) to 25.53 Cr., marking an increase of 2.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.48 Cr.. The value appears to be declining and may need further review. It has decreased from 66.80 Cr. (Mar 2025) to 66.48 Cr., marking a decrease of 0.32 Cr..
- For Total Assets, as of Sep 2025, the value is 92.01 Cr.. The value appears strong and on an upward trend. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
Notably, the Reserves (63.46 Cr.) exceed the Borrowings (4.27 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.10 | -11.71 | -8.11 | -11.91 | -4.95 | -2.22 | -8.53 | -1.61 | 2.76 | 3.94 | 7.96 | 7.07 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104.86 | 81.89 | 95.85 | 107.85 | 104.75 | 97.97 | 117.15 | 152.74 | 118.16 | 84.26 | 48.69 | 81.29 |
| Inventory Days | 122.33 | 122.96 | 125.55 | 97.65 | 94.25 | 48.38 | 86.94 | 26.46 | 44.52 | 73.29 | 85.42 | 83.60 |
| Days Payable | 116.39 | 103.11 | 133.73 | 112.70 | 125.12 | 100.77 | 129.33 | 116.19 | 107.32 | 91.02 | 70.78 | 59.89 |
| Cash Conversion Cycle | 110.79 | 101.73 | 87.67 | 92.80 | 73.88 | 45.57 | 74.76 | 63.01 | 55.36 | 66.53 | 63.33 | 105.00 |
| Working Capital Days | -51.28 | -58.39 | -26.90 | -19.34 | -1.67 | -14.04 | -21.04 | 15.51 | 31.40 | 34.31 | -2.76 | 11.49 |
| ROCE % | 9.41% | 12.54% | 11.88% | 14.95% | 15.55% | 21.49% | 10.26% | 16.34% | 20.97% | 18.81% | 22.47% | 20.47% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Diluted EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Cash EPS (Rs.) | 5.99 | 3.77 | 3.86 | 1.67 | 6.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Revenue From Operations / Share (Rs.) | 86.25 | 76.07 | 72.37 | 61.86 | 80.68 |
| PBDIT / Share (Rs.) | 13.05 | 10.30 | 10.14 | 6.78 | 12.12 |
| PBIT / Share (Rs.) | 11.30 | 8.97 | 9.16 | 5.80 | 11.24 |
| PBT / Share (Rs.) | 6.90 | 3.73 | 4.27 | 0.99 | 7.83 |
| Net Profit / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| NP After MI And SOA / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| PBDIT Margin (%) | 15.13 | 13.54 | 14.01 | 10.96 | 15.01 |
| PBIT Margin (%) | 13.10 | 11.79 | 12.65 | 9.37 | 13.93 |
| PBT Margin (%) | 7.99 | 4.90 | 5.90 | 1.61 | 9.70 |
| Net Profit Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| NP After MI And SOA Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| Return on Networth / Equity (%) | 9.80 | 6.24 | 7.89 | 2.04 | 16.37 |
| Return on Capital Employeed (%) | 18.04 | 14.61 | 18.75 | 12.66 | 25.77 |
| Return On Assets (%) | 3.94 | 2.34 | 3.09 | 0.79 | 6.93 |
| Long Term Debt / Equity (X) | 0.38 | 0.49 | 0.26 | 0.29 | 0.26 |
| Total Debt / Equity (X) | 0.90 | 1.07 | 0.93 | 0.96 | 0.86 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.80 | 0.75 | 1.13 |
| Current Ratio (X) | 1.32 | 1.29 | 1.00 | 1.22 | 1.26 |
| Quick Ratio (X) | 1.05 | 0.94 | 0.68 | 0.92 | 1.05 |
| Inventory Turnover Ratio (X) | 3.14 | 3.16 | 3.21 | 3.89 | 5.21 |
| Interest Coverage Ratio (X) | 2.97 | 1.97 | 2.07 | 1.41 | 3.55 |
| Interest Coverage Ratio (Post Tax) (X) | 1.96 | 1.47 | 1.59 | 1.14 | 2.58 |
| Enterprise Value (Cr.) | 32.07 | 17.74 | 19.77 | 13.95 | 17.73 |
| EV / Net Operating Revenue (X) | 0.90 | 0.56 | 0.66 | 0.54 | 0.53 |
| EV / EBITDA (X) | 5.96 | 4.18 | 4.73 | 4.99 | 3.55 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| Price / BV (X) | 1.36 | 0.48 | 0.70 | 0.56 | 0.86 |
| Price / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| EarningsYield | 0.07 | 0.12 | 0.11 | 0.03 | 0.18 |
After reviewing the key financial ratios for Cenlub Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Diluted EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Cash EPS (Rs.), as of Mar 17, the value is 5.99. This value is within the healthy range. It has increased from 3.77 (Mar 16) to 5.99, marking an increase of 2.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 86.25. It has increased from 76.07 (Mar 16) to 86.25, marking an increase of 10.18.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 13.05. This value is within the healthy range. It has increased from 10.30 (Mar 16) to 13.05, marking an increase of 2.75.
- For PBIT / Share (Rs.), as of Mar 17, the value is 11.30. This value is within the healthy range. It has increased from 8.97 (Mar 16) to 11.30, marking an increase of 2.33.
- For PBT / Share (Rs.), as of Mar 17, the value is 6.90. This value is within the healthy range. It has increased from 3.73 (Mar 16) to 6.90, marking an increase of 3.17.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For PBDIT Margin (%), as of Mar 17, the value is 15.13. This value is within the healthy range. It has increased from 13.54 (Mar 16) to 15.13, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 17, the value is 13.10. This value is within the healthy range. It has increased from 11.79 (Mar 16) to 13.10, marking an increase of 1.31.
- For PBT Margin (%), as of Mar 17, the value is 7.99. This value is below the healthy minimum of 10. It has increased from 4.90 (Mar 16) to 7.99, marking an increase of 3.09.
- For Net Profit Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 5. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For Return on Networth / Equity (%), as of Mar 17, the value is 9.80. This value is below the healthy minimum of 15. It has increased from 6.24 (Mar 16) to 9.80, marking an increase of 3.56.
- For Return on Capital Employeed (%), as of Mar 17, the value is 18.04. This value is within the healthy range. It has increased from 14.61 (Mar 16) to 18.04, marking an increase of 3.43.
- For Return On Assets (%), as of Mar 17, the value is 3.94. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 16) to 3.94, marking an increase of 1.60.
- For Long Term Debt / Equity (X), as of Mar 17, the value is 0.38. This value is within the healthy range. It has decreased from 0.49 (Mar 16) to 0.38, marking a decrease of 0.11.
- For Total Debt / Equity (X), as of Mar 17, the value is 0.90. This value is within the healthy range. It has decreased from 1.07 (Mar 16) to 0.90, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 0.79. It has decreased from 0.83 (Mar 16) to 0.79, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 17, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 16) to 1.32, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 17, the value is 1.05. This value is within the healthy range. It has increased from 0.94 (Mar 16) to 1.05, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 3.14. This value is below the healthy minimum of 4. It has decreased from 3.16 (Mar 16) to 3.14, marking a decrease of 0.02.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 2.97. This value is below the healthy minimum of 3. It has increased from 1.97 (Mar 16) to 2.97, marking an increase of 1.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 1.47 (Mar 16) to 1.96, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 17, the value is 32.07. It has increased from 17.74 (Mar 16) to 32.07, marking an increase of 14.33.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 16) to 0.90, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 17, the value is 5.96. This value is within the healthy range. It has increased from 4.18 (Mar 16) to 5.96, marking an increase of 1.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For Price / BV (X), as of Mar 17, the value is 1.36. This value is within the healthy range. It has increased from 0.48 (Mar 16) to 1.36, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For EarningsYield, as of Mar 17, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 16) to 0.07, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cenlub Industries Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.04% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.8% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.2 (Industry average Stock P/E: 51.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.9
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Plot No. 233 & 234, Sector-58, Faridabad Haryana 121004 | cenlub@ceblub.in www.cenlub.in |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Madhu Mittal | Chairman & Managing Director |
| Mr. Aman Mittal | Whole Time Director |
| Mr. Ansh Mittal | Whole Time Director |
| Mr. Dinesh Kaushal | Independent Director |
| Mr. Kamlesh Kumar Johari | Independent Director |
| Mr. Tarun Kumar Gupta | Independent Director |
FAQ
What is the intrinsic value of Cenlub Industries Ltd?
Cenlub Industries Ltd's intrinsic value (as of 12 December 2025) is 231.17 which is 1.84% higher the current market price of 227.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 106 Cr. market cap, FY2025-2026 high/low of 579/210, reserves of ₹63.46 Cr, and liabilities of 92.01 Cr.
What is the Market Cap of Cenlub Industries Ltd?
The Market Cap of Cenlub Industries Ltd is 106 Cr..
What is the current Stock Price of Cenlub Industries Ltd as on 12 December 2025?
The current stock price of Cenlub Industries Ltd as on 12 December 2025 is 227.
What is the High / Low of Cenlub Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cenlub Industries Ltd stocks is 579/210.
What is the Stock P/E of Cenlub Industries Ltd?
The Stock P/E of Cenlub Industries Ltd is 13.2.
What is the Book Value of Cenlub Industries Ltd?
The Book Value of Cenlub Industries Ltd is 146.
What is the Dividend Yield of Cenlub Industries Ltd?
The Dividend Yield of Cenlub Industries Ltd is 0.00 %.
What is the ROCE of Cenlub Industries Ltd?
The ROCE of Cenlub Industries Ltd is 20.5 %.
What is the ROE of Cenlub Industries Ltd?
The ROE of Cenlub Industries Ltd is 14.7 %.
What is the Face Value of Cenlub Industries Ltd?
The Face Value of Cenlub Industries Ltd is 10.0.